RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
| Research and development (TTM) | YoY | 5-year CAGR |
|---|---|---|
| $1.3B | +68.4% | 49.5% |
| Research and development (TTM) | $1.3B |
|---|---|
| YoY | +68.4% |
| 5-year CAGR | 49.5% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $987M | +66.7% |
| 2024 | $592M | +40.0% |
| 2023 | $423M | +67.2% |
| 2022 | $253M | +35.4% |
| 2021 | $187M | +41.4% |
| 2020 | $132M | +44.1% |
| 2019 | $92M | +79.6% |
| 2018 | $51M | — |